CN109535203B - Conjugated ligand bridged diarylamine and ruthenium-acetylene end group compound and application thereof - Google Patents

Conjugated ligand bridged diarylamine and ruthenium-acetylene end group compound and application thereof Download PDF

Info

Publication number
CN109535203B
CN109535203B CN201811409496.2A CN201811409496A CN109535203B CN 109535203 B CN109535203 B CN 109535203B CN 201811409496 A CN201811409496 A CN 201811409496A CN 109535203 B CN109535203 B CN 109535203B
Authority
CN
China
Prior art keywords
ruthenium
end group
diarylamine
methanol
conjugated ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811409496.2A
Other languages
Chinese (zh)
Other versions
CN109535203A (en
Inventor
欧亚平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hengyang Normal University
Original Assignee
Hengyang Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hengyang Normal University filed Critical Hengyang Normal University
Priority to CN201811409496.2A priority Critical patent/CN109535203B/en
Publication of CN109535203A publication Critical patent/CN109535203A/en
Application granted granted Critical
Publication of CN109535203B publication Critical patent/CN109535203B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)

Abstract

The invention discloses a conjugated ligand bridged diarylamine and ruthenium acetylene end group compound and application thereof, wherein the conjugated ligand bridged diarylamine and ruthenium acetylene end group compound I is as follows:
Figure DDA0001878155360000011
wherein R is H, Me or OMe, and the conjugate ligand Ar is phenyl, naphthyl or anthryl. The electrochemical method tests show that the compound has extremely strong electronic interaction between the end groups, can present two continuous single-electron oxidation-reduction processes, and the potential difference delta E can reach 496-540 mV. The conjugated ligand bridged diarylamine and ruthenium acetylene end group compound can be widely applied to molecular wire materials, and provides a new research idea for the development of mixed redox active end group molecular wires and molecular electrons in the future.

Description

Conjugated ligand bridged diarylamine and ruthenium-acetylene end group compound and application thereof
Technical Field
The invention relates to the field of organic synthesis, in particular to a conjugated ligand bridged diarylamine and ruthenium acetylene end group compound and application thereof.
Background
The transition metal ruthenium end group is widely applied to the design of metal organic molecular wires, so that the electron transport capability of the conjugate bridge ligand is researched. Triarylamine and derivatives thereof are important organic molecules, and have wide application in the fields of medical intermediates, pesticides, dye chemical industry, organic materials and the like, and are also commonly researched as organic photoelectric materials due to excellent charge transfer performance.
The ruthenium metal end group and the triarylamine have excellent electrochemical activity and stability, for example, the excellent properties of the ruthenium metal end group and the triarylamine can be combined together, and a compound with strong electronic interaction between the end groups is synthesized, so that the development of the molecular lead material is greatly promoted, but no relevant report is found in the prior art at present.
Disclosure of Invention
The invention aims to provide a conjugated ligand bridged diarylamine and ruthenium acetylene end group compound with extremely strong electronic interaction between end groups.
In order to solve the technical problems, the invention adopts the following technical scheme: a conjugated ligand bridged diarylamine and ruthenium acetylene end group compound has a structural formula I shown as follows:
Figure BDA0001878155340000021
wherein R is H, Me or OMe, and conjugate ligand Ar is phenyl, naphthyl or anthryl;
the phenyl is selected from:
Figure BDA0001878155340000022
one of (1);
the naphthyl group is selected from:
Figure BDA0001878155340000023
one of (1);
the anthracene group is selected from:
Figure BDA0001878155340000024
one kind of (1).
It will be clear to those skilled in the art that the above "Me" is methyl (CH)3) International acronym for english.
When the conjugated ligand Ar is
Figure BDA0001878155340000025
And when R is OMe, the conjugated ligand bridged diarylamine and ruthenium acetylene end group compound has the structural formula I-1 shown as follows:
Figure BDA0001878155340000031
the corresponding preparation method comprises the following steps:
a. under the protection of nitrogen, pentamethyl cyclopentadienyl (1, 2-bis diphenyl phosphine ethane) ruthenium chloride Cp*Ru (dppe) Cl, 4-trimethylsilylethynyl-N, N-di (4-methoxyphenyl) -1-aniline) and potassium fluoride are dissolved in a mixed solution of methanol and tetrahydrofuran, heated and refluxed for 22-28h, and then cooled to room temperature;
b. performing suction filtration, washing the obtained solid with methanol and n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane;
c. and (3) selecting acetone and petroleum ether as eluent to carry out column chromatography separation to obtain the product.
In the above preparation method, pentamethylcyclopentadienyl (1, 2-bisdiphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 4-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-aniline) and potassium fluoride in a molar ratio of 6: 5: 40, adding methanol according to the proportion that each 1mmol of potassium fluoride corresponds to 10ml of methanol, adding tetrahydrofuran according to the proportion that each 1mmol of potassium fluoride corresponds to 1.5-2ml of tetrahydrofuran, wherein the volume ratio of acetone to petroleum ether in the eluent is 1: 2.
II, when the conjugated ligand Ar is
Figure BDA0001878155340000041
And when R is OMe, the structural formula I-2 of the diarylamine and ruthenium acetylene end group compound bridged by the conjugated ligand is as follows:
Figure BDA0001878155340000042
the corresponding preparation method comprises the following steps:
a. under the protection of nitrogen, pentamethyl cyclopentadienyl (1, 2-bis diphenyl phosphine ethane) ruthenium chloride Cp*Ru (dppe) Cl, 3-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-aniline) and potassium fluoride are dissolved in a mixed solution of methanol and tetrahydrofuran, heated and refluxed for 22 to 28 hours, and then cooled to room temperature;
b. performing suction filtration, washing the obtained solid with methanol and n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane;
c. and (3) selecting acetone and petroleum ether as eluent to carry out column chromatography separation to obtain the product.
In the above preparation method, pentamethylcyclopentadienyl (1, 2-bisdiphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 3-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-phenylamine) and potassium fluoride in a molar ratio of 6: 5: 40, adding methanol according to the proportion that each 1mmol of potassium fluoride corresponds to 10ml of methanol, adding tetrahydrofuran according to the proportion that each 1mmol of potassium fluoride corresponds to 1.5-2ml of tetrahydrofuran, wherein the volume ratio of acetone to petroleum ether in the eluent is 1: 2.
when the conjugated ligand Ar is
Figure BDA0001878155340000051
When R is OMe, the structural formula I-3 of the diarylamine and ruthenium acetylene end group compound bridged by the conjugated ligand is as follows:
Figure BDA0001878155340000052
the corresponding preparation method comprises the following steps:
a. pentamethylcyclopentadienyl (1, 2-bis-diphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 4-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-naphthylamine) and potassium fluoride are dissolved in a mixed solution of methanol and tetrahydrofuran, heated and refluxed for 22-28h, and then cooled to room temperature;
b. and (4) carrying out suction filtration, washing the obtained solid with methanol and n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane to obtain the compound.
In the above preparation method, pentamethylcyclopentadienyl (1, 2-bisdiphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 4-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-naphthylamine) and potassium fluoride in a molar ratio of 6: 5: 40, methanol is added in a ratio of 10ml per 1mmol of potassium fluoride, and tetrahydrofuran is added in a ratio of 1mmol of potassium fluoride1ml of tetrahydrofuran is added.
When the conjugated ligand Ar is
Figure BDA0001878155340000061
And when R is OMe, the structural formula I-4 of the diarylamine and ruthenium acetylene end group compound bridged by the conjugated ligand is as follows:
Figure BDA0001878155340000062
the corresponding preparation method comprises the following steps:
a. pentamethylcyclopentadienyl (1, 2-bis-diphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 10-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -9-anthrylamine) and potassium fluoride are dissolved in a mixed solution of methanol and tetrahydrofuran, heated and refluxed for 22-28h, and then cooled to room temperature;
b. and (4) carrying out suction filtration, washing the obtained solid with methanol and n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane to obtain the compound.
In the above preparation method, pentamethylcyclopentadienyl (1, 2-bisdiphenylphosphinoethane) ruthenium chloride Cp*The molar ratio between ru (dppe) Cl, 10-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -9-anthracenamine) and potassium fluoride was 6: 5: 40 methanol is added in a proportion of 10ml methanol per 1mmol potassium fluoride and tetrahydrofuran is added in a proportion of 1ml tetrahydrofuran per 1mmol potassium fluoride.
Compared with the prior art, the invention has the following beneficial effects: the invention selects ruthenium metal end group and diarylamine as oxidation-reduction active end group respectively, compounds with brand-new structure are synthesized by phenyl, naphthyl or anthryl bridging, and the electrochemical method tests show that the end groups of the compounds have extremely strong electronic interaction and can present two continuous single-electron oxidation-reduction processes, and the potential difference delta E reaches 496-540 mV. The conjugated ligand bridged diarylamine and ruthenium acetylene end group compound can be widely applied to molecular wire materials, and provides a new research idea for the development of mixed redox active end group molecular wires and molecular electrons in the future.
Drawings
FIG. 1 shows the NMR spectrum of the compound obtained in example 1.
FIG. 2 shows the NMR spectrum of the compound obtained in example 1.
FIG. 3 shows the NMR phosphorus spectrum of the compound obtained in example 1.
FIG. 4 shows the NMR spectrum of the compound obtained in example 2.
FIG. 5 shows the NMR spectrum of the compound obtained in example 2.
FIG. 6 shows the NMR phosphorus spectrum of the compound obtained in example 2.
FIG. 7 shows the NMR spectrum of the compound obtained in example 3.
FIG. 8 is a NMR spectrum of the compound obtained in example 3.
FIG. 9 shows the NMR phosphorus spectrum of the compound obtained in example 3.
FIG. 10 shows the NMR spectrum of the compound obtained in example 4.
FIG. 11 is a NMR spectrum of the compound obtained in example 4.
FIG. 12 shows the NMR phosphorus spectrum of the compound obtained in example 4.
Detailed Description
The following examples are given to illustrate the present invention and it should be noted that the following examples are only for illustrative purposes and should not be construed as limiting the scope of the present invention, and that the modification and modification of the present invention by those of ordinary skill in the art are not essential to the present invention.
Example 1
A conjugated ligand bridged diarylamine and ruthenium acetylene end group compound has a structural formula I-1 shown as follows:
Figure BDA0001878155340000081
the method for preparing the conjugated ligand bridged diarylamine and ruthenium acetylene end group compound comprises the following steps:
a. under the protection of nitrogen, 0.3mmol (1, 2-bis diphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 0.25mmol of 4-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-aniline) and 2mmol of potassium fluoride were dissolved in a mixed solution of 20ml of methanol and 3-4ml of tetrahydrofuran, heated under reflux for 24 hours and then cooled to room temperature;
b. performing suction filtration, washing the obtained solid with 10ml of methanol and 10ml of n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane;
c. selecting a volume ratio of 1: 2, and performing column chromatography separation by using acetone and petroleum ether as eluent to obtain 150mg of yellow crystals with the yield of 62%.
The nuclear magnetic resonance carbon spectrogram, nuclear magnetic resonance hydrogen spectrogram and nuclear magnetic resonance phosphorus spectrogram of the product are respectively shown in figure 1, figure 2 and figure 3.
Elemental analysis (C)61H66NO2P2Ru): theoretical value: c, 72.67; h, 6.60. Measurement value: c, 72.59; h, 6.65.
Structural data:1H NMR(500MHz,CDCl3):δ1.55(s,15H,CH3),2.05(br,2H),2.68(br,2H),3.77(s,6H),6.66(dd,J(HH)=10.0Hz,4H),6.77(d,J(HH)=10.0Hz,4H),6.98(dd,J(HH)=10.0Hz,4H),7.19-7.33(m,16H,dppe-Ph and Ar),7.79(s,4H)。
13C NMR(125MHz,CDCl3):δ10.10(CH3),29.47(CH2),55.53(OCH3),92.46(C5H5),114.43,121.90,125.50,127.17,127.21,127.41,127.45,128.84,130.77,133.24,133.84,133.88,141.80,154.98。
31P NMR(200MHz,CDCl3):δ80.93。
example 2
A conjugated ligand bridged diarylamine and ruthenium acetylene end group compound has a structural formula I-2 shown as follows:
Figure BDA0001878155340000091
the method for preparing the conjugated ligand bridged diarylamine and ruthenium acetylene end group compound comprises the following steps:
a. under the protection of nitrogen, 0.3mmol of pentamethylcyclopentadienyl (1, 2-bis-diphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 0.25mmol of 3-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-aniline) and 2mmol of potassium fluoride were dissolved in a mixed solution of 20ml of methanol and 3-4ml of tetrahydrofuran, heated under reflux for 24 hours and then cooled to room temperature;
b. performing suction filtration, washing the obtained solid with 10ml of methanol and 10ml of n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane;
c. selecting a volume ratio of 1: 2, and carrying out column chromatography separation by using acetone and petroleum ether as eluent to obtain 167mg of light yellow crystals with the yield of 69%.
The nuclear magnetic resonance carbon spectrogram, nuclear magnetic resonance hydrogen spectrogram and nuclear magnetic resonance phosphorus spectrogram of the product are respectively shown in fig. 4, fig. 5 and fig. 6.
Elemental analysis (C)61H66NO2P2Ru): theoretical value: c, 72.67; h, 6.60. Measurement value: c, 72.49; h, 6.68.
Structural data:1H NMR(500MHz,CDCl3):δ1.52(s,15H,CH3),2.02(br,2H),2.62(br,2H),3.79(s,6H),6.43(d,J(HH)=5.0Hz,1H),6.52(d,J(HH)=5.0Hz,1H),6.56(s,1H),6.81(d,J(HH)=5.0Hz,4H),6.86(t,J(HH)=10.0Hz,1H),7.01(d,J(HH)=5.0Hz,1H),7.14-7.33(m,16H,dppe-Ph andAr),7.72(t,J(HH)=10.0Hz,4H)。
13C NMR(125MHz,CDCl3):δ9.99(CH3),29.49(CH2),55.53(OCH3),92.52(C5H5),109.52,114.47,117.22,123.75,124.19,125.88,127.04,127.08,127.11,127.31,127.34,127.38,127.90,128.77,133.19,133.62,133.66,133.70,136.65,137.03,138.86,139.12,141.88,147.93,155.21。
31P NMR(200MHz,CDCl3):δ80.91。
example 3
A conjugated ligand bridged diarylamine and ruthenium acetylene end group compound has a structural formula I-3 shown as follows:
Figure BDA0001878155340000111
the method for preparing the conjugated ligand bridged diarylamine and ruthenium acetylene end group compound comprises the following steps:
a. 0.3mmol of pentamethylcyclopentadienyl (1, 2-bisdiphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 0.25mmol of 4-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-naphthylamine) and 2mmol of potassium fluoride were dissolved in a mixed solution of 20ml of methanol and 2ml of tetrahydrofuran, heated under reflux for 24 hours, and then cooled to room temperature;
b. suction filtration, washing the resulting solid with 10ml methanol and 10ml n-hexane respectively, followed by recrystallization with dichloromethane and n-hexane gave 180mg of a tea green solid, yield: 68 percent.
The nuclear magnetic resonance carbon spectrogram, nuclear magnetic resonance hydrogen spectrogram and nuclear magnetic resonance phosphorus spectrogram of the product are respectively shown in fig. 7, fig. 8 and fig. 9.
Elemental analysis (C)65H68NO2P2Ru): theoretical value: c, 73.77; h, 6.48. Measurement value: c, 73.69; h, 6.52.
Structural data:1H NMR(500MHz,CDCl3):δ1.62(s,15H,CH3),2.13(br,2H),2.27(br,2H),3.75(s,6H),6.72(s,2H),6.73(d,J(HH)=5.0Hz,2H),6.91-6.93(m,6H),7.16-7.33(m,16H),7.80(d,J(HH)=10.0Hz,6H)。
13C NMR(125MHz,CDCl3):δ10.19(CH3),29.48(CH2),55.52(OCH3),92.79(C5H5),108.38,114.32,122.76,123.68,124.46,125.21,126.39,127.39,127.43,127.47,127.51,128.58,128.86,128.95,133.11,133.16,133.20,133.75,133.79,133.82,143.03,154.08。
31P NMR(200MHz,CDCl3):δ81.20。
example 4
A conjugated ligand bridged diarylamine and ruthenium acetylene end group compound has a structural formula I-4 shown as follows:
Figure BDA0001878155340000121
the method for preparing the conjugated ligand bridged diarylamine and ruthenium acetylene end group compound comprises the following steps:
a. 0.3mmol of pentamethylcyclopentadienyl (1, 2-bisdiphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 0.25mmol of 10-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -9-anthracenamine) and 2mmol of potassium fluoride were dissolved in a mixed solution of 20ml of methanol and 2ml of tetrahydrofuran, heated under reflux for 24 hours, and then cooled to room temperature;
b. and (3) performing suction filtration, washing the obtained solid with 10ml of methanol and 10ml of n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane to obtain 170mg of tea green solid, wherein the yield is as follows: 61 percent.
The nuclear magnetic resonance carbon spectrogram, nuclear magnetic resonance hydrogen spectrogram and nuclear magnetic resonance phosphorus spectrogram of the product are respectively shown in fig. 10, fig. 11 and fig. 12.
Elemental analysis (C)69H70NO2P2Ru): theoretical value: c, 74.77; h, 6.37. Measurement value: c, 74.83; h, 6.34.
Structural data:1H NMR(500MHz,CDCl3):δ1.69(s,15H,CH3),2.16(br,2H),2.90(br,2H),3.70(s,6H),6.68(d,J(HH)=10.0Hz,4H),6.81(t,J(HH)=10.0Hz,2H),6.98(d,J(HH)=10.0Hz,4H),7.11-7.38(m,18H,dppe-Ph andAn),7.55(t,J(HH)=10.0Hz,4H),7.89(d,J(HH)=10.0Hz,2H),7.94(d,J(HH)=5.0Hz,2H)。
13C NMR(125MHz,CDCl3):δ10.37(CH3),29.48(CH2),55.47(OCH3),93.16(C5H5),109.05,114.31,120.83,123.15,123.69,125.79,127.47,127.50,127.55,129.01,129.18,129.58,133.28,133.70,137.21,138.46,138.73,142.27,146.78,153.41。
31PNMR(200MHz,CDCl3):δ81.22。
electrochemical measurement test
The adopted equipment comprises the following steps: electrochemical workstation CHI 660C (CH Instruments Company, USA).
Using glassy carbon electrode as working electrode, platinum electrode as counter electrode, Ag+And the | Ag electrode is a reference electrode. At 0.001mol L-1n-Bu4NPF6CH (A) of2Cl2The solution is electrolyte, and the concentration of the measured substrate is 0.001mol L-1
Cyclic voltammetry is usually performed at a scan rate of 100mV s-1The square wave voltammetry was measured at f ═ 10 Hz.
Data processing: the data were processed into pictures by OriginPro 8.0.
The conjugated ligand bridged diarylamine and ruthenium acetylene end group compounds are subjected to cyclic voltammetry and square wave voltammetry tests by an electrochemical method to obtain a potential difference delta E and an equilibrium constant Kc value of two times of oxidation reduction, and the results are shown in Table 1.
TABLE 1 electrochemical test data for conjugated ligand bridged diarylamines and ruthenium acetylene end-group compounds
Compound (I) E1/2(1)(V) E1/2(2)(V) ΔE(mV)b Kc c
I-1 0.165 0.665 500 2.83×108
I-2 0.357 0.853 496 1.98×108
I-3 0.176 0.703 527 6.53×108
I-4 0.170 0.710 540 1.07×109
As can be seen from Table 1, the compounds prepared by the invention all present two continuous single-electron redox processes, and the potential difference Delta E of the two redox processes obtained by testing can reach 496-540mV, and the results show that the terminal groups of the conjugated ligand bridged diarylamine and ruthenium acetylene terminal group compounds provided by the invention present extremely strong electronic interaction (coupling).

Claims (9)

1. A conjugated ligand bridged diarylamine and ruthenium acetylene end group compound is characterized in that the structural formula I is as follows:
Figure FDA0002889899490000011
wherein R is OMe, and the conjugate ligand Ar is phenyl, naphthyl or anthryl;
the phenyl is selected from:
Figure FDA0002889899490000012
one of (1);
the naphthyl group is:
Figure FDA0002889899490000013
the anthracene group is as follows:
Figure FDA0002889899490000014
2. the method for preparing the conjugated ligand bridged diarylamine and the ruthenium-acetylene end group compound is characterized in that the conjugated ligand bridged diarylamine and the ruthenium-acetylene end group compound have the structural formula I-1 shown as follows:
Figure FDA0002889899490000021
the corresponding preparation process comprises the following steps:
a. under the protection of nitrogen, pentamethyl cyclopentadienyl (1, 2-bis diphenyl phosphine ethane) ruthenium chloride Cp*Ru (dppe) Cl, 4-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-phenylamine and potassium fluoride were dissolved in a mixed solution of methanol and tetrahydrofuran, and the mixture was refluxedCooling to room temperature after 22-28 h;
b. performing suction filtration, washing the obtained solid with methanol and n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane;
c. and (3) selecting acetone and petroleum ether as eluent to carry out column chromatography separation to obtain the product.
3. The method for preparing the conjugated ligand bridged diarylamine and the ruthenium-acetylene end group compound is characterized in that the conjugated ligand bridged diarylamine and the ruthenium-acetylene end group compound have the structural formula I-2 shown as follows:
Figure FDA0002889899490000022
the corresponding preparation process comprises the following steps:
a. under the protection of nitrogen, pentamethyl cyclopentadienyl (1, 2-bis diphenyl phosphine ethane) ruthenium chloride Cp*Ru (dppe) Cl, 3-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-aniline and potassium fluoride are dissolved in a mixed solution of methanol and tetrahydrofuran, heated and refluxed for 22-28h, and then cooled to room temperature;
b. performing suction filtration, washing the obtained solid with methanol and n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane;
c. and (3) selecting acetone and petroleum ether as eluent to carry out column chromatography separation to obtain the product.
4. A process according to claim 2 or 3 for the preparation of conjugated ligand bridged diarylamines and ruthenium acetylene end group compounds, characterized in that: the volume ratio of acetone to petroleum ether is 1: 2.
5. a process according to claim 2 or 3 for the preparation of conjugated ligand bridged diarylamines and ruthenium acetylene end group compounds, characterized in that: methanol is added in a ratio of 10ml methanol per 1mmol potassium fluoride, and tetrahydrofuran is added in a ratio of 1.5-2ml tetrahydrofuran per 1mmol potassium fluoride.
6. The method for preparing the conjugated ligand bridged diarylamine and the ruthenium-acetylene end group compound is characterized in that the conjugated ligand bridged diarylamine and the ruthenium-acetylene end group compound have the structural formula I-3 shown as follows:
Figure FDA0002889899490000031
the corresponding preparation process comprises the following steps:
a. pentamethylcyclopentadienyl (1, 2-bis-diphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 4-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -1-naphthylamine and potassium fluoride are dissolved in a mixed solution of methanol and tetrahydrofuran, heated and refluxed for 22-28h, and then cooled to room temperature;
b. and (4) carrying out suction filtration, washing the obtained solid with methanol and n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane to obtain the compound.
7. The method for preparing the conjugated ligand bridged diarylamine and the ruthenium-acetylene end group compound is characterized in that the conjugated ligand bridged diarylamine and the ruthenium-acetylene end group compound have the structural formula I-4 shown as follows:
Figure FDA0002889899490000041
the corresponding preparation process comprises the following steps:
a. pentamethylcyclopentadienyl (1, 2-bis-diphenylphosphinoethane) ruthenium chloride Cp*Ru (dppe) Cl, 10-trimethylsilylethynyl-N, N-bis (4-methoxyphenyl) -9-anthrylamine and potassium fluoride are dissolved in a mixed solution of methanol and tetrahydrofuran, heated and refluxed for 22-28h, and then cooled to room temperature;
b. and (4) carrying out suction filtration, washing the obtained solid with methanol and n-hexane respectively, and then recrystallizing with dichloromethane and n-hexane to obtain the compound.
8. A process according to claim 6 or 7 for the preparation of conjugated ligand bridged diarylamines and ruthenium acetylene end group compounds, characterized in that: methanol was added in a ratio of 10ml of methanol per 1mmol of potassium fluoride, and tetrahydrofuran was added in a ratio of 1ml of tetrahydrofuran per 1mmol of potassium fluoride.
9. The use of a conjugated ligand-bridged diarylamine and ruthenium acetylene end group compound as claimed in claim 1 in molecular wire materials.
CN201811409496.2A 2018-11-23 2018-11-23 Conjugated ligand bridged diarylamine and ruthenium-acetylene end group compound and application thereof Active CN109535203B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811409496.2A CN109535203B (en) 2018-11-23 2018-11-23 Conjugated ligand bridged diarylamine and ruthenium-acetylene end group compound and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811409496.2A CN109535203B (en) 2018-11-23 2018-11-23 Conjugated ligand bridged diarylamine and ruthenium-acetylene end group compound and application thereof

Publications (2)

Publication Number Publication Date
CN109535203A CN109535203A (en) 2019-03-29
CN109535203B true CN109535203B (en) 2021-02-23

Family

ID=65850058

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811409496.2A Active CN109535203B (en) 2018-11-23 2018-11-23 Conjugated ligand bridged diarylamine and ruthenium-acetylene end group compound and application thereof

Country Status (1)

Country Link
CN (1) CN109535203B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111205336A (en) * 2020-02-28 2020-05-29 衡阳师范学院 Pyridine-bridged double-ruthenium acetylene end group compound and preparation method and application thereof
CN112851716B (en) * 2021-01-25 2023-03-21 衡阳师范学院 Terpyridyl ruthenium acetylene triphenylamine compound and preparation method and application thereof
CN112920229A (en) * 2021-02-01 2021-06-08 衡阳师范学院 Fe-N inorganic-organic heteronuclear molecular wire and construction method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103601757A (en) * 2012-06-29 2014-02-26 纳米与先进材料研发有限公司 Low-bandgap ruthenium-containing complexes for solution-processed organic solar cells
CN107056845A (en) * 2017-04-25 2017-08-18 衡阳师范学院 Triaryl amine and ferrocene end group compound of phenyl bridging and its preparation method and application

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103601757A (en) * 2012-06-29 2014-02-26 纳米与先进材料研发有限公司 Low-bandgap ruthenium-containing complexes for solution-processed organic solar cells
CN107056845A (en) * 2017-04-25 2017-08-18 衡阳师范学院 Triaryl amine and ferrocene end group compound of phenyl bridging and its preparation method and application

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Eduard Kovalski等.Synthesis, Electrochemistry, and Optical Properties of Half-Sandwich Ruthenium Complexes Bearing Triarylamine-Anthracenes.《Eur. J. Inorg. Chem.》.2018,第671-675页. *
L2=(PPh3)2,Cp’=Cp;L2=dppe;Cp’=Cp*).《Journal of Organometallic Chemistry》.2007, *
Mark A. Fox等.Spectroscopic properties and electronic structures of 17-electronhalf-sandwich ruthenium acetylide complexes, [Ru(CCAr)(L2)Cp’]+(Ar=phenyl, p-tolyl, 1-naphthyl, 9-anthryl *
Synthesis, Electrochemistry, and Optical Properties of Half-Sandwich Ruthenium Complexes Bearing Triarylamine-Anthracenes;Eduard Kovalski等;《Eur. J. Inorg. Chem.》;20180122;第671-675页 *
α-取代苯并噻吩钌乙炔及钌乙烯配合物的合成、表征、电化学及光谱电化学性质;欧亚平等;《无机化学学报》;20160410(第04期);第641-648页 *

Also Published As

Publication number Publication date
CN109535203A (en) 2019-03-29

Similar Documents

Publication Publication Date Title
CN109535203B (en) Conjugated ligand bridged diarylamine and ruthenium-acetylene end group compound and application thereof
Bell et al. Self-assembly of a double-helical complex of sodium
Caron et al. Selective electrosynthesis of dimethylfullerene [(CH3) 2C60]: a novel method for the controlled functionalization of fullerenes
CN107056845B (en) Triaryl amine and ferrocene end group compound of phenyl bridging and its preparation method and application
CN109651449B (en) Conjugated ligand bridged ferrocene and ruthenium acetylene end group compound and preparation method and application thereof
CN108456310B (en) Strip-shaped single-layer metal organic polymer sheet and preparation method thereof
CN113150036B (en) Triarylamine substituted terpyridyl ruthenium complex and preparation method and application thereof
CN111875641A (en) Preparation method and application of trifluoromethyl modified platinum complex
CN111205336A (en) Pyridine-bridged double-ruthenium acetylene end group compound and preparation method and application thereof
Albright et al. The balance of steric and electronic factors in tricobalt cluster geometry: synthesis, structure, computations, and electrochemistry of tris [dicarbonyl (. mu.-dicyclohexylphosphido) cobalt]
CN109336776B (en) Large steric hindrance alkoxy substituted conjugated compound with triarylamine as end group and application thereof
CN113150035B (en) Linear asymmetric N-Ru-N redox center terpyridyl ruthenium complex and preparation method and application thereof
CN112851716B (en) Terpyridyl ruthenium acetylene triphenylamine compound and preparation method and application thereof
Pramanik et al. Chemistry of ruthenium phenolates. Synthesis, characterization and redox properties of a group of salicylaldiminato complexes of ruthenium
Uccello‐Barretta et al. Overall view of the use of chiral platinum (II) complexes as chiral derivatizing agents (CDAs) for the enantiodiscrimination of unsaturated compounds by 195Pt NMR
Kadish et al. Electrochemistry of (TPP) Mo (O)(OCH3) and (TPP) Mo (O) in dichloromethane
CN105175297A (en) Synthesis and application of 4-formyl benzoic acid adamantine ester condensed o-aminobenzene thiophenol schiff base nickel complex
Giannetto et al. Self‐Assembly of Hexameric Macrocycles from PtII/Ferrocene Dimetallic Subunits–Synthesis, Characterization, Chemical Reactivity, and Oxidation Behavior
CN104098611A (en) Carbon atom bridged chain type multi-ferrocene compound synthesizing method
CN111217840B (en) Linear phenanthroline copper complex and preparation method and application thereof
CN112409415A (en) Cyclometalated diyne platinum (II) complex and preparation method and application thereof
CN115772115B (en) Synthesis method of aryl pyridine bromo-derivative
CN115215720B (en) Graphene nano fragment molecule containing azulene unit-azulene and jade red province and synthesis method and application thereof
CN112920229A (en) Fe-N inorganic-organic heteronuclear molecular wire and construction method and application thereof
CN113105643A (en) Preparation and application of two-dimensional chiral Organometallics Framework

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant